Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-29 Purchase | 2023-11-30 08:00 am | SAB Biotherapeutics Inc. | SABS | Reich Samuel J Executive Chairman | 11,000 | $0.8947 | $9,842 | 766,699 (Indirect Direct) | View |
| 2021-10-14 Purchase | 2021-10-15 10:48 am | Big Cypress Acquisition Corp. | BCYP | Reich Samuel J CEO and CFO 10% Owner | 1,000 | $10.11 | $10,110 | 3,048,825 (Indirect Direct) | View |
| 2021-01-14 Purchase | 2021-01-14 1:33 pm | Big Cypress Acquisition Corp. | BCYP | Reich Samuel J CEO and CFO 10% Owner | 417,200 | $10 | $4,172,000 | 3,047,825 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-21 Option Award | 2024-02-23 4:40 pm | N/A 2034-02-21 | SAB Biotherapeutics Inc. | SABS | Reich Samuel J CEO & EXECUTIVE CHAIRMAN | 434,000 | $0 | 434,000 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-16 4:28 pm | N/A 2033-03-14 | SAB Biotherapeutics Inc. | SABS | Reich Samuel J Executive Chairman | 525,000 | $0 | 525,000 (Direct) | View |
| 2023-02-28 Other | 2023-03-02 09:18 am | 2022-01-14 2026-10-20 | SAB Biotherapeutics Inc. | SABS | Reich Samuel J Executive Chairman | 218,568 | $0 | 9,968 (Indirect) | View |
| 2022-09-13 Option Award | 2022-09-15 5:15 pm | N/A 2032-09-13 | SAB Biotherapeutics Inc. | SABS | Reich Samuel J Executive Chairman | 525,000 | $0 | 525,000 (Direct) | View |
| 2022-05-20 Other | 2022-05-23 5:45 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Reich Samuel J Executive Chairman | 2,707,128 | $0 | 3,462,827 (Indirect) | View |
| 2022-03-16 Option Award | 2022-03-18 9:15 pm | N/A 2032-03-16 | SAB Biotherapeutics Inc. | SABS | Reich Samuel J Executive Chairman | 7,000 | $0 | 7,000 (Direct) | View |
| 2021-11-17 Option Award | 2021-11-19 4:05 pm | N/A 2031-11-17 | SAB Biotherapeutics Inc. | SABS | Reich Samuel J Executive Chairman | 350,000 | $0 | 350,000 (Direct) | View |
Ownership | 2021-01-11 5:00 pm | N/A N/A | Big Cypress Acquisition Corp. | BCYP | Reich Samuel J CEO and CFO 10% Owner | 0 | $0 | 2,630,625 (Indirect) | View |